---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "AF Stroke Risk"
developer_entity: "Putu Angga Risky Raharja"
bundle_id: "com.imedicalapps.atrialfibrillationstrokerisk"
app_store_id: "1508729810"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2021-08-13"
report_date: "2026-09-23"
last_verified: "2026-09-23T00:00:00.000Z"
report_version: "3.1"
total_reviews: 1
overall_rating: 1
confidence: "low"
confidence_score: 0
data_age_days: 14
momentum_velocity: "zombie"
intelligence_version: 2
tags: ["medical", "free", "mobile app", "app review", "app analysis", "medical", "practitioners", "requiring"]
canonical_url: "https://marlvel.ai/apps/af-stroke-risk"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# AF Stroke Risk Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 1

> **TL;DR:** AF Stroke Risk is a medical app by Putu Angga Risky Raharja, rated 1/5 by 1 users, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** AF Stroke Risk is a medical app by Putu Angga Risky Raharja.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 1/5 (1 review) |
| **Category** | Medical |
| **Developer** | Putu Angga Risky Raharja |
| **Pricing** | Free |
| **Platforms** | iOS |
| **Confidence** | Low (0/1.0) |
| **Data Age** | 14d |

## Metadata & Market Performance
- **Publisher:** Putu Angga Risky Raharja
- **Category:** Medical
- **Target Audience:** Medical practitioners requiring quick access to clinical stroke risk stratification tools.
- **Platforms:** iOS
- **Version Reviewed:** 3.1
- **Report Date:** 2026-09-23
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0/1.0)
- **App Store ID (iOS):** 1508729810
- **Bundle ID:** com.imedicalapps.atrialfibrillationstrokerisk
- **Data Window:** Analysis based on signals collected up to 2026-09-23

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** AF Stroke Risk is a medical utility for practitioners to calculate stroke risk scores in patients with atrial fibrillation on iOS.
**Why users hire it:** It removes the manual calculation friction of clinical prediction rules, allowing for faster risk stratification during patient consultations.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] CHA₂DS₂-VASc Calculator:** Clinical prediction tool for estimating stroke risk in patients with non-rheumatic atrial fibrillation.
- **[Standard] CHADS₂ Score Calculator:** Clinical prediction rule for stroke risk stratification in atrial fibrillation patients.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

AF Stroke Risk operates as a niche medical utility with no recent development activity since 2021. Its position is defined by a single-purpose focus on cardiac risk scores, contrasting with broader medical suites that aggregate multiple diagnostic tools.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Fully free access
- **Analysis:** The app is distributed as a free utility with no visible monetization or subscription tiers.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Standardized clinical prediction rules automate risk stratification
- Zero-cost access lowers barriers for clinical adoption

**Growth Levers:**
- Update clinical guidelines to maintain diagnostic relevance
- Expand into patient-facing educational content


<!-- /section:swot -->
<!-- section:whats-new -->
## What's New

- **Latest (v3.1, 5 years ago):** General bug fixes and performance optimizations.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- No updates since August 2021.
- Maintenance-mode status limits feature expansion.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 1866 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

AF Stroke Risk is a medical app that is completely free.
It holds a 1/5 rating from 1 review.

<!-- speakable-start -->
> **Bottom Line:** AF Stroke Risk serves as a functional, static utility, but the lack of updates since 2021 limits its long-term viability against evolving clinical standards. Ensuring the accuracy of its risk stratification logic is the primary requirement to maintain its utility for practitioners.
<!-- speakable-end -->

**Best for:** Medical practitioners requiring quick access to clinical stroke risk stratification tools.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [MAINTAIN] Audit clinical guidelines because the app has not been updated since 2021 → ensure diagnostic accuracy
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The medical calculator market is consolidating around comprehensive, frequently updated suites that offer multi-score integration. AF Stroke Risk remains a static, single-purpose tool, which limits its ability to compete for practitioners who require up-to-date diagnostic compliance.

- ⚪ The app remains in maintenance mode with no updates for over five years, signaling a lack of active competitive intent.
- 🔴 Static clinical calculators risk obsolescence as medical guidelines evolve, potentially eroding the tool's clinical reliability for practitioners.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 1/5 |
| Total Reviews | 1 |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | iOS |
| Key Features | 2 analyzed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **AF Stroke Risk** (this app) | 1/5 | N/A | Putu Angga Risky Raharja |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Putu Angga Risky Raharja
- **Website:** [https://apps.apple.com/us/developer/putu-angga-risky-raharja/id1164107753?uo=4](https://apps.apple.com/us/developer/putu-angga-risky-raharja/id1164107753?uo=4)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/af-stroke-risk/id1508729810?uo=4)
- **Dev Site:** [Official Website](https://apps.apple.com/us/developer/putu-angga-risky-raharja/id1164107753?uo=4)
- **Sources:** App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 14 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/af-stroke-risk)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.